Target intelligence / Profile preview

Vacuolar ATPase assembly factor VMA12 (VMA12)

Target
VMA12
Molecular classification
Other (assembly chaperone/cofactor), Transmembrane protein
01

Overview

Vacuolar ATPase assembly factor VMA12 (VMA12) is a transmembrane protein located in the endoplasmic reticulum (ER) that acts as a dedicated assembly factor (chaperone) for the membrane-embedded V0 sector of the vacuolar-type H+-ATPase (V-ATPase) proton pump. It participates in the recruitment and stabilization of V-ATPase membrane subunits during assembly, interacting with Vma22 and subunits a, e, and f to promote proper V-ATPase formation[1][3]. VMA12 is not part of the mature V-ATPase proton pump complex itself, but is essential for its biogenesis and quality control, ensuring only properly assembled complexes are exported from the ER. Mutations in the human orthologs (including TMEM199) result in congenital disorders of glycosylation and liver disease, as well as defects in endolysosomal acidification[1]. VMA12 is not a therapeutic target per se, and no known drugs directly target this assembly factor.

Other names
VMA12Vacuolar ATPase assembly protein VMA12C17orf32TMEM199VPH2MGC45714Transmembrane protein 199CDG2P
02

Biological functions

Organelle acidification (by facilitating V-ATPase assembly)Protein complex assembly (specifically V-ATPase V0 complex)Endoplasmic reticulum protein homeostasis
03

Disease associations

Congenital disorders of glycosylationLysosomal disease (via defective V-ATPase assembly)Other (e.g., X-linked myopathy with excessive autophagy, follicular lymphoma)
04

Safety considerations

Loss-of-function causes multisystem disorders (hepatic, neurological)Disruption impacts lysosomal/ER homeostasis

Beyond the preview

Go deeper on Vacuolar ATPase assembly factor VMA12 (VMA12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vacuolar ATPase assembly factor VMA12 (VMA12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call